Watson Files ANDA With FDA To Market Sevelamer Carbonate
Watson’s Sevelamer carbonate tablet is the generic version of Genzyme’s Renvela, a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
RoundTable has committed to support Renaissance Pharma with the full resources of the firm including substantial investment capital. RoundTable said that Mr Frechette brings experience to Renaissance Pharma